News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
804,475 Results
Type
Article (61753)
Company Profile (362)
Press Release (742346)
Multimedia
Podcasts (161)
Webinars (22)
Section
Business (218710)
Career Advice (2649)
Deals (37922)
Drug Delivery (167)
Drug Development (86990)
Employer Resources (181)
FDA (17903)
Job Trends (16349)
News (372193)
Policy (36319)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2989)
Accelerated approval (58)
ADA (49)
Adcomms (40)
Allergies (205)
Alliances (53706)
ALS (237)
Alzheimer's disease (1945)
Antibody-drug conjugate (ADC) (541)
Approvals (18291)
Artificial intelligence (800)
ASCO (342)
Autoimmune disease (357)
Automation (65)
Bankruptcy (383)
Best Places to Work (12373)
BIOSECURE Act (21)
Biosimilars (242)
Biotechnology (230)
Bladder cancer (209)
Brain cancer (84)
Breast cancer (831)
Cancer (6544)
Cardiovascular disease (539)
Career advice (2251)
Career pathing (51)
CAR-T (374)
CDC (70)
Celiac Disease (3)
Cell therapy (1012)
Cervical cancer (56)
Clinical research (75475)
Collaboration (2342)
Commercialization (1)
Company closure (6)
Compensation (1503)
Complete response letters (101)
COVID-19 (3000)
CRISPR (124)
C-suite (1282)
Cystic fibrosis (167)
Data (8762)
Decentralized trials (3)
Denatured (59)
Depression (193)
Dermatology (96)
Diabetes (698)
Diagnostics (7436)
Digital health (68)
Diversity (14)
Diversity, equity & inclusion (47)
Drug discovery (384)
Drug pricing (234)
Drug shortages (37)
Duchenne muscular dystrophy (312)
Earnings (95778)
Editorial (78)
Employer branding (22)
Employer resources (160)
Events (129484)
Executive appointments (1179)
FDA (21987)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1945)
Gene editing (264)
Generative AI (72)
Gene therapy (816)
GLP-1 (1233)
Government (5270)
Grass and pollen (8)
Guidances (420)
Healthcare (20839)
Hematology (197)
HIV (94)
Huntington's disease (65)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (339)
Immuno-oncology (113)
Indications (213)
Infectious disease (3395)
Inflammatory bowel disease (239)
Inflation Reduction Act (15)
Influenza (147)
Intellectual property (318)
Interviews (451)
IPO (17534)
IRA (55)
Job creations (4280)
Job search strategy (1865)
JPM (67)
Kidney cancer (22)
Labor market (112)
Layoffs (641)
Leadership (51)
Legal (8898)
Liver cancer (110)
Longevity (36)
Lung cancer (868)
Lymphoma (480)
Machine learning (66)
Management (62)
Manufacturing (1196)
Marketing (1)
MASH (220)
Medical affairs (1)
Medical device (15174)
Medtech (15343)
Mergers & acquisitions (21706)
Metabolic disorders (1778)
mRNA (261)
Multiple sclerosis (204)
NASH (22)
Neurodegenerative disease (494)
Neuropsychiatric disorders (126)
Neuroscience (3680)
Neurotech (1)
NextGen: Class of 2026 (7281)
Non-profit (5018)
Now hiring (81)
Obesity (840)
Opinion (361)
Ovarian cancer (244)
Pain (282)
Pancreatic cancer (359)
Parkinson's disease (414)
Partnered (36)
Patents (647)
Patient recruitment (769)
Peanut (71)
People (64276)
Pharmaceutical (78)
Pharmacy benefit managers (37)
Phase 1 (23448)
Phase 2 (33123)
Phase 3 (24768)
Pipeline (9873)
Policy (372)
Postmarket research (2932)
Preclinical (10164)
Press Release (71)
Prostate cancer (348)
Psychedelics (66)
Radiopharmaceuticals (374)
Rare diseases (1268)
Real estate (6649)
Recruiting (73)
Regulatory (28198)
Reports (60)
Research institute (2705)
Resumes & cover letters (426)
Rett syndrome (43)
RNA editing (28)
RSV (98)
Schizophrenia (194)
Series A (332)
Series B (242)
Service/supplier (13)
Sickle cell disease (123)
Special edition (31)
Spinal muscular atrophy (185)
Sponsored (51)
Startups (4170)
State (2)
Stomach cancer (21)
Supply chain (141)
Tariffs (97)
The Weekly (100)
Vaccines (1278)
Venture capital (127)
Weight loss (567)
Women's health (141)
Worklife (23)
Date
Last 7 days (524)
Last 30 days (2543)
Last 365 days (31874)
2026 (16241)
2025 (31747)
2024 (36961)
2023 (41961)
2022 (53281)
2021 (58049)
2020 (56918)
2019 (50269)
2018 (38177)
2017 (35168)
2016 (35386)
2015 (41306)
2014 (35133)
2013 (30601)
2012 (32786)
2011 (33408)
2010 (32057)
Location
Africa (954)
Alabama (95)
Alaska (7)
Arizona (387)
Arkansas (16)
Asia (45753)
Australia (7682)
California (14201)
Canada (3973)
China (1557)
Colorado (614)
Connecticut (636)
Delaware (444)
Europe (102143)
Florida (2126)
Georgia (468)
Hawaii (3)
Idaho (68)
Illinois (1215)
India (102)
Indiana (644)
Iowa (25)
Japan (604)
Kansas (140)
Kentucky (54)
Louisiana (61)
Maine (76)
Maryland (1728)
Massachusetts (10359)
Michigan (393)
Minnesota (790)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (154)
New Hampshire (91)
New Jersey (3749)
New Mexico (33)
New York (3758)
North Carolina (1870)
North Dakota (11)
Northern California (7129)
Ohio (434)
Oklahoma (27)
Oregon (47)
Pennsylvania (2814)
Puerto Rico (32)
Rhode Island (54)
South America (1338)
South Carolina (88)
South Dakota (2)
Southern California (5621)
Tennessee (231)
Texas (2293)
United States (50696)
Utah (423)
Vermont (2)
Virginia (357)
Washington D.C. (85)
Washington State (1162)
West Virginia (4)
Wisconsin (147)
Wyoming (2)
804,475 Results for "ra medical systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pancreatic cancer
ASCO: Revolution poised to capture RAS space as pancreatic cancer dataset ‘derisks’ approval
Revolution Medicines and its RAS inhibitor daraxonrasib stole the show at the American Society of Clinical Oncology’s annual meeting this weekend, as Truist Securities predicts a possible third quarter launch for the pancreatic cancer drug.
June 1, 2026
·
3 min read
·
Brianna Abbott
Leadership
BBOT shakes up leadership as RAS competitors get more visibility
Chief Scientific Officer Pedro Beltran will succeed Eli Wallace as CEO of BridgeBio Oncology Therapeutics, as the board eyes a busy period of clinical advancement in the RAS oncology space.
April 23, 2026
·
2 min read
·
Annalee Armstrong
Funding
RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq
While RA Capital Management has yet to commit to a merger plan, it noted that its new blank-check company, Research Alliance III, could target companies abroad, including those from China.
March 25, 2026
·
2 min read
·
Tristan Manalac
Press Releases
IDEAYA Biosciences Announces Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer
June 3, 2026
·
5 min read
Press Releases
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
June 16, 2026
·
8 min read
Press Releases
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
June 12, 2026
·
1 min read
Press Releases
Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches
June 1, 2026
·
4 min read
Press Releases
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
April 20, 2026
·
11 min read
Press Releases
Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide
June 8, 2026
·
11 min read
Press Releases
Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer
May 4, 2026
·
5 min read
1 of 80,448
Next
